CIRBP and neoplasm: In addition, CIRP is thought to be involved in the progression of ductal carcinoma into invasive breast cancer presumably by increasing the expression of CyclinE1, an important cell cycle regulator, thereby promoting proliferation and tumor progression in breast cancer transformation [82, 90, 142].